Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.
about
Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial.Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck.The National Institute for Health and Clinical Excellence, and otolaryngology: review of the evidence.
P2860
Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Radiochemoimmunotherapy with i ...... m analysis of the REACH trial.
@ast
Radiochemoimmunotherapy with i ...... m analysis of the REACH trial.
@en
type
label
Radiochemoimmunotherapy with i ...... m analysis of the REACH trial.
@ast
Radiochemoimmunotherapy with i ...... m analysis of the REACH trial.
@en
prefLabel
Radiochemoimmunotherapy with i ...... m analysis of the REACH trial.
@ast
Radiochemoimmunotherapy with i ...... m analysis of the REACH trial.
@en
P2093
P2860
P356
P1433
P1476
Radiochemoimmunotherapy with i ...... m analysis of the REACH trial.
@en
P2093
Alexandra D Jensen
Anna V Nikoghosyan
Christian Simon
Jürgen Krauss
Karen Lossner
Karin Potthoff
Marc W Münter
P2860
P2888
P356
10.1186/1748-717X-7-57
P50
P577
2012-04-02T00:00:00Z
P6179
1004925215